Fig. 4
From: Blood leukocytes as a non-invasive diagnostic tool for thyroid nodules: a prospective cohort study
Performance of the BLDM model in classifying MTN and BTN samples in both non-micronodules and micronodules within the validation cohort. A Area under the curve (AUC) scores of the BLDM model and US for non-micronodules. B Comparing the performance of the BLDM model and US in non-micronodules. C The diagnostic performance of the BLDM model for non-micronodules across different ACT TI-RADS categories. D AUC scores of the BLDM model and US for micronodules. E Comparing the performance of the BLDM model and US in micronodules. F The diagnostic performance of the BLDM model for micronodules across different ACT TI-RADS categories. BTN, benign thyroid nodule; MTN, malignant thyroid nodule; US, ultrasonography